Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: Report of the phase II trial RTOG 0024

Journal of Clinical Oncology

Volumn 27, Issue 28, 2009, Pages 4727-4732

  Rosenthal, David I ^a   Harris, Jonathan ^a   Forastiere, Arlene A ^a   Weber, Randal S ^a   Ridge, John A ^a   Myers, Jeffrey N ^a   Garden, Adam S ^a   Kuettel, Michael R ^a   Sidhu, Kulbir ^a   Schultz, Christopher J ^a   Trotti, Andy ^a   Ang, K Kian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ALLERGY; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DISEASE; BONE DISEASE; BONE MARROW DEPRESSION; BONE NECROSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENDOCRINE DISEASE; ESOPHAGUS DISEASE; FEBRILE NEUTROPENIA; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HEARING DISORDER; HEART ARRHYTHMIA; HUMAN; LARYNX DISORDER; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MUCOSAL DISEASE; NEPHROTOXICITY; NEUROTOXICITY; PAIN; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SEXUAL DYSFUNCTION; SKIN TOXICITY; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; TUMOR CELL; XEROSTOMIA; ADULT; AGED; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; SKIN DISEASE; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY; SKIN DISEASES; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350433284     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.4197     Document Type: Article

References (23)

1. Fu KK, Pajak TF, Trotti A, et al: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
2. Laramore G, Scott C, al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23:705-713, 1992
3. Rosenthal D, Liu L, Lee J, et al: Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 24:115-126, 2002
4. Bernier J, Domenge C, Ozsahin M, et al: Head and neck cancer. N Engl J Med 350:1945-1952, 2004
5. Cooper J, Pajak TJ, Forastiere AA, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350:1937-1944, 2004
6. Ang KK, Trotti A, Brown BW, et al: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571-578, 2001
7. Bernier J, Cooper J, Pajak TF, et al: Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843-850, 2005
8. Hanahan D, Weinberg R: The hallmarks of cancer. Cell 100:57-70, 2000
9. Licitra LF, Perrone F, Tamborini E, et al: Effect of antityrosyne kinase agents on in vitro tumor cell proliferation induced by wound drainage fluids (WDFs) of head and neck cancer (HNSCC) patients. J Clin Oncol 26:335s, 2008 (suppl; abstr 6077)
10. O'Reilly M: The interaction of radiation therapy and antiangiogenic therapy. Cancer J 14:207-213, 2008
11. Poulsen MG, Denham JW, Peters LJ, et al: A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: A Trans-Tasman radiation oncology group study. Radiother Oncol 60:113-122, 2001
12. Retsky MW, Demicheli R, Swartzendruber DE, et al: Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 45:193-202, 1997
13. Devita V: The James Ewing lecture: The relationship between tumor mass and resistance to chemotherapy - Implications for surgical adjuvant treatment of cancer. Cancer 51:1209-1220, 1983
14. Peters LJ, Withers HR: Applying radiobiological principles to combined modality treatment of head and neck cancer: The time factor. Int J Radiat Oncol Biol Phys 39:831-836, 1997
15. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
16. Kalbfleisch J, Prentice R: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley, 1980
17. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Dixon D, Simon R: Sample size considerations for studies comparing curves using historical controls. J Clin Epidemiol 41:1209-1213, 1988
19. Cox D: Regression models and life tables. J R Stat Soc 34:187-229, 1972
20. Chang I, Gelman R, Pagano M: Corrected group prognostic curves and summary statistics. J Chronic Dis 35:669-674, 1982
21. Byers RM, Clayman GL, Guillamondequi OM, et al: Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck 14:133-138, 1992
22. Yu P, Robb G: Pharyngoesophageal reconstruction with the anterolateral thigh flap: A clinical and functional outcomes study. Plast Reconstr Surg 116:1845-1855, 2005
23. Khuri F, Lee J, Lippman S, et al: Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 98:441-450, 2006